Table 1 Clinicopathological characteristics of patients included in the discovery proteomics
Feature | Control n =12 | Relapse n = 12 |
|---|---|---|
Planned tamoxifen regimen | ||
2 years | 1 | 5 |
5 years | 11 | 7 |
Age, years | ||
Median | 61.6 | 65.1 |
Range | 38–79 | 36–84 |
Tumor size | ||
T1 | 5 | 5 |
T2 | 4 | 5 |
T3 | 3 | 2 |
Lymph-node status | ||
Node-negative | 5 | 5 |
Node-positive | 7 | 7 |
1–3 | 3 | 2 |
≥4 | 4 | 5 |
ER (fmol/μg DNA) | ||
Median | 1.8 | 1.0 |
Average | 2.7 | 1.4 |
Range | 0.52–9.4 | 0.08–4.1 |
PgR (fmol/μg DNA) | ||
Median | 2.3 | 0.6 |
Average | 4.1 | 2.4 |
Range | 0–16.9 | 0–12.8 |